机构

• 上海药物研究所 [14]
• 长春应用化学研究所 [7]
• 化学研究所 [2]
• 过程工程研究所 [2]
• 高能物理研究所 [2]
• 宁波材料技术与工程研... [1]
• 更多

采集方式

• OAI收割 [31]
• iSwitch采集 [2]

内容类型

• 期刊论文 [33]

发表日期

• 2024 [1]
• 2023 [2]
• 2022 [4]
• 2021 [1]
• 2020 [3]
• 2019 [2]
• 更多

学科主题

• Materials ... [2]
• 分析化学与药物化学 [1]

筛选

浏览/检索结果: 共33条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors 期刊论文  OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32 作者:  Wei, Qing;  Li, Peijing;  Yang, Teng;  Zhu, Jiayu;  Sun, Lu   |  收藏  |  浏览/下载：57/0  |  提交时间：2024/02/27 Antibody-drug conjugate  Solid tumor  Combination therapy  Immunotherapy  Targeted therapy   Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12 作者:  Lin, Ting-ting;  Xiong, Wei;  Chen, Gui-hua;  He, Yang;  Long, Li   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/01/26 osimertinib resistance  targeted drug delivery  liposomes  panobinostat  tumor-associated macrophage  combination therapy   Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 6, 页码: 2601-2612 作者:  Wang, Xiaomin;  Xu, Jun;  Sun, Yiming;  Cao, Siyuwei;  Zeng, Hanlin   |  收藏  |  浏览/下载：46/0  |  提交时间：2023/10/17 HDAC inhibitors  Drug resistance  Histone methylation  Histone acetylation  Epigenetic interplay  Hedgehog pathway  ZIC1  LIFR  Combination therapy  Breast cancer   Antitumor pharmacological research in the era of personalized medicine 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 卷号: 43, 期号: 12, 页码: 3015-3020 作者:  Huang, Min;  Geng, Mei-yu;  Ding, Jian   |  收藏  |  浏览/下载：15/0  |  提交时间：2023/04/10 personalized medicine  anticancer drug discovery  oncogene addiction  non-oncogene addiction  combination therapy   Targeting PI3K alpha overcomes resistance to KRas(G12C) inhibitors mediated by activation of EGFR and/or IGF1R 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 12 作者:  Qi, Wei-liang;  Li, Hui-yu;  Wang, Yi;  Xu, Lan;  Deng, Jie-ting   |  收藏  |  浏览/下载：24/0  |  提交时间：2023/04/10 AMG510  KRas(G12C)  PI3K  drug resistance  combination therapy   Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities 期刊论文  OAI收割 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 7, 页码: 14 作者:  Lin, Jian;  Dai, Yuting;  Sang, Chen;  Song, Guohe;  Xiang, Bin   |  收藏  |  浏览/下载：57/0  |  提交时间：2022/08/30 tumor microenvironment  cytotoxicity  immunologic  drug therapy  combination   Self-assembled Pt(II) metallacycles enable precise cancer combination chemotherapy 期刊论文  OAI收割 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 卷号: 119 作者:  Zhang, Pengge;  Zhou, Zhixuan;  Long, Wen;  Yan, Yuping;  Li, Youshan   |  收藏  |  浏览/下载：31/0  |  提交时间：2022/12/22 self-assembly  supramolecular coordination complex  combination chemotherapy  targeted cancer therapy  drug delivery   Teaching new tricks to old dogs: A review of drug repositioning of disulfiram for cancer nanomedicine 期刊论文  OAI收割 View, 2021, 卷号: 2, 期号: 4, 页码: 20200127 作者:  Zhao, Pengfei;  Tang, Xueping;  Huang, Yongzhuo   |  收藏  |  浏览/下载：14/0  |  提交时间：2024/03/14 combination therapy  disulfiram  drug repositioning  nanotechnology  tumor-targetingdelivery   Supramolecular Drug-Drug Complex Vesicles Enable Sequential Drug Release for Enhanced Combination Therapy 期刊论文  OAI收割 ACS APPLIED MATERIALS & INTERFACES, 2020, 卷号: 12, 期号: 25, 页码: 27940-27950 作者:  Liu, Chengfei;  Li, Chunpu;  Pang, Cui;  Li, Muqiong;  Li, Huixin   |  收藏  |  浏览/下载：25/0  |  提交时间：2020/12/24 drug-drug self-delivery system  supramolecular vesicles  host-guest interaction  self-assembly  pillar[5]arene  combination therapy   Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy 期刊论文  OAI收割 FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 卷号: 8, 页码: 8 作者:  Tu, Bin;  Zhang, Meng;  Liu, Tuanbing;  Huang, Yongzhuo   |  收藏  |  浏览/下载：21/0  |  提交时间：2020/12/24 Histone deacetylase inhibitors (HDACi)  nanotechnology  nanomedicine  cancer therapy  solid tumor  targeting drug delivery  combination therapy